{
  "id": "ngn_sa_trend_205",
  "itemType": "standalone_trend",
  "caseId": "msr_205",
  "paradigm": "ngn",
  "version": "2.0.0",
  "seed": "BATCH-300-205-1771351755489",
  "status": "active",
  "cjjm": {
    "step": "analyzeCues"
  },
  "cognitiveSkill": "nursingProcess_assessment",
  "difficulty": 4,
  "client": {
    "age": "42 years",
    "gender": "Male",
    "setting": "Emergency Department",
    "background": "The client has a 5-year history of relapsing-remitting multiple sclerosis (RRMS) and is treated with ocrelizumab infusions every 6 months. His last infusion was 3 weeks ago. He is a high school history teacher.",
    "presenting": "The client presents to the emergency department with a 3-day history of worsening fatigue, blurred vision in his right eye, and a 'pins and needles' sensation that started in his feet and has now progressed up to his knees."
  },
  "tabs": [
    {
      "id": "tab1",
      "title": "Neurology Follow-up (1 month ago)",
      "content": {
        "notes": [
          {
            "type": "note",
            "time": "1400",
            "author": "Neurologist, MD",
            "text": "Client seen for routine follow-up for RRMS. Reports feeling well, fatigue is at baseline. No new or worsening neurological symptoms. Neurological exam is stable and at his baseline. Scheduled for next ocrelizumab infusion in 1 week. Discussed importance of avoiding infection and managing stress."
          }
        ],
        "vitals": [
          {
            "label": "Temperature",
            "value": "37.0째C (98.6째F)"
          },
          {
            "label": "Heart Rate",
            "value": "72 bpm"
          },
          {
            "label": "Respirations",
            "value": "16/min"
          },
          {
            "label": "Blood Pressure",
            "value": "124/78 mmHg"
          },
          {
            "label": "SpO2",
            "value": "99% on room air"
          }
        ],
        "assessments": [
          {
            "label": "Neurological",
            "value": "Alert and oriented x4. Speech clear. Cranial nerves II-XII grossly intact. Vision clear bilaterally. Strength 5/5 in all extremities. Sensation intact to light touch throughout. Coordination and gait are at client's baseline, no new deficits."
          }
        ]
      }
    },
    {
      "id": "tab2",
      "title": "ED Triage Note (Today)",
      "content": {
        "notes": [
          {
            "type": "note",
            "time": "0915",
            "author": "Triage Nurse, RN",
            "text": "Client presents with chief complaint of worsening MS symptoms over the last 3 days. Reports new onset blurred vision in right eye, which he describes as 'looking through a smudge.' Also reports paresthesia that began in his toes and is now 'up to my knees.' States fatigue is 'overwhelming' and much worse than his baseline."
          }
        ],
        "vitals": [
          {
            "label": "Temperature",
            "value": "37.2째C (99.0째F)"
          },
          {
            "label": "Heart Rate",
            "value": "94 bpm"
          },
          {
            "label": "Respirations",
            "value": "18/min"
          },
          {
            "label": "Blood Pressure",
            "value": "138/84 mmHg"
          },
          {
            "label": "SpO2",
            "value": "98% on room air"
          }
        ]
      }
    },
    {
      "id": "tab3",
      "title": "ED Assessment Note (Today, 2 hours after triage)",
      "content": {
        "notes": [
          {
            "type": "note",
            "time": "1120",
            "author": "Emergency Department Nurse, RN",
            "text": "Client is anxious but cooperative. Expresses concern about missing work. He reports difficulty buttoning his shirt this morning. Denies fever, chills, or any signs of infection. Denies recent trauma or illness."
          }
        ],
        "assessments": [
          {
            "label": "Neurological",
            "value": "Alert and oriented x4. Speech clear but slightly slowed. Nystagmus noted on right lateral gaze. Right pupil sluggish to react to light. Visual acuity decreased in right eye. Sensation to light touch diminished from the toes to just below the knees bilaterally. Muscle strength 4/5 in bilateral lower extremities, 5/5 in upper extremities. Mild dysmetria noted on finger-to-nose test."
          }
        ]
      }
    }
  ],
  "prompt": "The nurse reviews the client's record. Which 3 findings are the most significant indicators of a potential multiple sclerosis relapse?",
  "item": {
    "type": "multi_choice",
    "multiSelect": true,
    "selectN": 3,
    "options": [
      {
        "id": "opt_1",
        "label": "History of relapsing-remitting MS"
      },
      {
        "id": "opt_2",
        "label": "New onset nystagmus on right lateral gaze"
      },
      {
        "id": "opt_3",
        "label": "Blood pressure of 138/84 mmHg"
      },
      {
        "id": "opt_4",
        "label": "Paresthesia ascending to the knees"
      },
      {
        "id": "opt_5",
        "label": "Bilateral lower extremity strength of 4/5"
      },
      {
        "id": "opt_6",
        "label": "Last ocrelizumab infusion was 3 weeks ago"
      }
    ]
  },
  "answer": [
    "opt_2",
    "opt_4",
    "opt_5"
  ],
  "answerBreakdown": {
    "title": "Rationale",
    "points": [
      {
        "optionId": "opt_1",
        "isCorrect": false,
        "rationale": "Incorrect. While the client's history of RRMS provides context, it's not an acute indicator of a relapse. It's baseline information. RRMS is characterized by periods of relapses (exacerbations) and remissions. This history makes him susceptible, but isn't a new finding.",
        "scoring": "-"
      },
      {
        "optionId": "opt_2",
        "isCorrect": true,
        "rationale": "Correct. Nystagmus, involuntary eye movement, indicates demyelination affecting the brainstem or cerebellum. MS lesions disrupt nerve pathways, causing impaired eye muscle control. This new onset points to an active inflammatory process and is a key sign of an MS relapse.",
        "pathophysiology": "Demyelination disrupts the transmission of nerve impulses in the brainstem or cerebellum, leading to impaired coordination of eye movements. The resulting imbalance in muscle control causes the eyes to move involuntarily, producing nystagmus.",
        "scoring": "+"
      },
      {
        "optionId": "opt_3",
        "isCorrect": false,
        "rationale": "Incorrect. The blood pressure is mildly elevated but is a non-specific finding. It could be due to anxiety or pain. It doesn't directly reflect neurological changes associated with MS.",
        "scoring": "-"
      },
      {
        "optionId": "opt_4",
        "isCorrect": true,
        "rationale": "Correct. Ascending paresthesia (pins and needles) indicates demyelination along the spinal cord. MS lesions disrupt sensory pathways, causing abnormal sensations. The ascending pattern suggests a progressive inflammatory process affecting the spinal cord.",
        "pathophysiology": "Demyelination of sensory nerve fibers in the spinal cord disrupts the normal transmission of sensory signals. This leads to abnormal sensations such as tingling, numbness, or burning, which can ascend as the inflammation spreads.",
        "scoring": "+"
      },
      {
        "optionId": "opt_5",
        "isCorrect": true,
        "rationale": "Correct. Decreased lower extremity strength (4/5) indicates demyelination affecting motor pathways in the brain or spinal cord. MS lesions disrupt nerve impulses, causing muscle weakness. This new motor deficit is a significant sign of an MS relapse.",
        "pathophysiology": "Demyelination of motor nerve fibers disrupts the transmission of signals from the brain to the muscles. This leads to muscle weakness, spasticity, and impaired motor control. A strength of 4/5 indicates weakness against gravity with some resistance.",
        "scoring": "+"
      },
      {
        "optionId": "opt_6",
        "isCorrect": false,
        "rationale": "Incorrect. While the timing of the ocrelizumab infusion is relevant for treatment considerations, it's not a clinical finding indicating a relapse. It's part of his treatment history.",
        "scoring": "-"
      }
    ]
  },
  "sbar": {
    "situation": "0915: A 42-year-old male with relapsing-remitting multiple sclerosis presents to the ED with a 3-day history of worsening fatigue, blurred vision in the right eye, and paresthesia ascending from his feet to his knees.",
    "background": "The client receives ocrelizumab infusions every 6 months, last dose 3 weeks ago. One month prior, at a neurology follow-up, he reported feeling well with no new neurological symptoms.",
    "assessment": "1120: The client exhibits new onset nystagmus on right lateral gaze, sluggish pupillary reaction in the right eye, decreased visual acuity in the right eye, ascending paresthesia to the knees, and decreased lower extremity strength (4/5 bilaterally). Mild dysmetria is present.",
    "recommendation": "Neurological consultation is recommended to evaluate for an MS relapse. Consider MRI and initiating treatment for acute exacerbation. Monitor neurological status closely."
  },
  "clinicalPearls": [
    "In MS, new or worsening neurological symptoms should prompt evaluation for a relapse.",
    "Common relapse symptoms include fatigue, vision changes, sensory disturbances, and motor weakness.",
    "Nystagmus, ascending paresthesia, and new motor deficits are key indicators of a potential MS relapse.",
    "While elevated BP can occur, it's not specific to MS relapse.",
    "Recent ocrelizumab infusion doesn't rule out relapse; breakthrough exacerbations can occur."
  ],
  "sentinelStatus": "healed_v2026_v8"
}